These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32860345)

  • 61. Case Report: Responsive Neurostimulation of the Centromedian Thalamic Nucleus for the Detection and Treatment of Seizures in Pediatric Primary Generalized Epilepsy.
    Welch WP; Hect JL; Abel TJ
    Front Neurol; 2021; 12():656585. PubMed ID: 33995254
    [TBL] [Abstract][Full Text] [Related]  

  • 62. DBS of Thalamic Centromedian Nucleus for Lennox-Gastaut Syndrome (ESTEL Trial).
    Dalic LJ; Warren AEL; Bulluss KJ; Thevathasan W; Roten A; Churilov L; Archer JS
    Ann Neurol; 2022 Feb; 91(2):253-267. PubMed ID: 34877694
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis.
    Talwar A; Estes E; Aparasu R; Reddy DS
    Exp Neurol; 2023 Jan; 359():114238. PubMed ID: 36206805
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term prognosis of patients with Lennox--Gastaut syndrome in recent decades.
    Kim HJ; Kim HD; Lee JS; Heo K; Kim DS; Kang HC
    Epilepsy Res; 2015 Feb; 110():10-9. PubMed ID: 25616450
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A 7-Year-Old Boy with Intractable Seizures and Snoring.
    Arevalo C; DelRosso LM; Khaytin I; Brown L
    J Clin Sleep Med; 2016 Jun; 12(6):920-3. PubMed ID: 26951404
    [No Abstract]   [Full Text] [Related]  

  • 66. Second-line cannabis therapy in patients with epilepsy.
    Braun E; Gualano FM; Siddarth P; Segal E
    Clin Neurol Neurosurg; 2023 Apr; 227():107638. PubMed ID: 36870086
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical characteristics of children and young adults with co-occurring autism spectrum disorder and epilepsy.
    El Achkar CM; Spence SJ
    Epilepsy Behav; 2015 Jun; 47():183-90. PubMed ID: 25599987
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lennox-Gastaut syndrome in adulthood: Long-term clinical follow-up of 38 patients and analysis of their recorded seizures.
    Vignoli A; Oggioni G; De Maria G; Peron A; Savini MN; Zambrelli E; Chiesa V; La Briola F; Turner K; Canevini MP
    Epilepsy Behav; 2017 Dec; 77():73-78. PubMed ID: 29126048
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Autism and epilepsy: a retrospective follow-up study.
    Hara H
    Brain Dev; 2007 Sep; 29(8):486-90. PubMed ID: 17321709
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Frontoparietal
    Balfroid T; Warren AEL; Dalic LJ; Aeby A; Berlangieri SU; Archer JS
    Epilepsy Res; 2023 May; 192():107131. PubMed ID: 37054522
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Brain-responsive neurostimulation for epilepsy (RNS
    Skarpaas TL; Jarosiewicz B; Morrell MJ
    Epilepsy Res; 2019 Jul; 153():68-70. PubMed ID: 30850259
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
    Devinsky O; Marsh E; Friedman D; Thiele E; Laux L; Sullivan J; Miller I; Flamini R; Wilfong A; Filloux F; Wong M; Tilton N; Bruno P; Bluvstein J; Hedlund J; Kamens R; Maclean J; Nangia S; Singhal NS; Wilson CA; Patel A; Cilio MR
    Lancet Neurol; 2016 Mar; 15(3):270-8. PubMed ID: 26724101
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
    Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
    CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Deep Brain Stimulation of the Centromedian Nucleus of the Thalamus for Lennox-Gastaut Syndrome: A Systematic Review and Individual Patient Data Analysis.
    Shlobin NA; Hofmann K; Cohen NT; Koubeissi MZ; Gaillard WD; Oluigbo CO
    Neurosurgery; 2023 Apr; 92(4):703-715. PubMed ID: 36700706
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.
    Lattanzi S; Trinka E; Russo E; Striano P; Citraro R; Silvestrini M; Brigo F
    Drugs Today (Barc); 2019 Mar; 55(3):177-196. PubMed ID: 30938373
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Responsive Neurostimulation for the Treatment of Children With Drug-Resistant Epilepsy in Tuberous Sclerosis Complex.
    Karakas C; Houck K; Handoko M; Trandafir C; Coorg R; Haneef Z; Riviello JJ; Weiner HL; Curry D; Ali I
    Pediatr Neurol; 2023 Aug; 145():97-101. PubMed ID: 37302216
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Abnormal cognitive network interactions in Lennox-Gastaut syndrome: A potential mechanism of epileptic encephalopathy.
    Warren AE; Abbott DF; Vaughan DN; Jackson GD; Archer JS
    Epilepsia; 2016 May; 57(5):812-22. PubMed ID: 26945476
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
    Thiele EA; Marsh ED; French JA; Mazurkiewicz-Beldzinska M; Benbadis SR; Joshi C; Lyons PD; Taylor A; Roberts C; Sommerville K;
    Lancet; 2018 Mar; 391(10125):1085-1096. PubMed ID: 29395273
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neurostimulation in generalized epilepsy: A systematic review and meta-analysis.
    Haneef Z; Skrehot HC
    Epilepsia; 2023 Apr; 64(4):811-820. PubMed ID: 36727550
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Therapeutic approach to Lennox-Gastaut syndrome: a systematic review.
    Borrelli S; El Tahry R
    Acta Neurol Belg; 2019 Sep; 119(3):315-324. PubMed ID: 31286465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.